225 related articles for article (PubMed ID: 2137939)
1. Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy.
Raziuddin S; Nur MA; al-Wabel AA
Scand J Immunol; 1990 Feb; 31(2):139-45. PubMed ID: 2137939
[TBL] [Abstract][Full Text] [Related]
2. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
Raziuddin S; Danial HB; Kelley M
Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
[TBL] [Abstract][Full Text] [Related]
3. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.
Maeda N; Sekigawa I; Iida N; Matsumoto M; Hashimoto H; Hirose S
Scand J Rheumatol; 1999; 28(3):166-70. PubMed ID: 10380839
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus.
Raziuddin S; Nur MA; Alwabel AA
J Rheumatol; 1989 Oct; 16(10):1315-9. PubMed ID: 2530345
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
7. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
Tsuchiya N; Mitamura T; Goto M; Moroi Y; Kinoshita M; Yokohari R; Miyamoto T
J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
[TBL] [Abstract][Full Text] [Related]
8. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.
Inghirami G; Simon J; Balow JE; Tsokos GC
Clin Exp Rheumatol; 1988; 6(3):269-76. PubMed ID: 3263240
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus.
Viallard JF; Bloch-Michel C; Neau-Cransac M; Taupin JL; Garrigue S; Miossec V; Mercie P; Pellegrin JL; Moreau JF
Clin Exp Immunol; 2001 Sep; 125(3):485-91. PubMed ID: 11531958
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
[TBL] [Abstract][Full Text] [Related]
11. HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.
Janssen RA; Buter J; Straatsma E; Heijn AA; Sleijfer DT; de Vries EG; Mulder NH; The TH; de Leij L
Cancer Immunol Immunother; 1993; 36(3):198-204. PubMed ID: 8439981
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
13. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 production by alloantigen-stimulated CD4+ and CD8+ human T cell subsets: frequency of HLA class I or class II-reactive precursor cells and clonal specificity of activated T cells.
Jooss J; Eiermann TH; Wagner H; Kabelitz D
Immunobiology; 1989 Oct; 179(4-5):366-81. PubMed ID: 2575597
[TBL] [Abstract][Full Text] [Related]
15. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.
Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C
Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
[TBL] [Abstract][Full Text] [Related]
17. Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus.
Matsushita M; Hayashi T; Ando S; Sekigawa I; Iida N; Hashimoto H; Hirose S
Clin Rheumatol; 2000; 19(4):270-4. PubMed ID: 10941806
[TBL] [Abstract][Full Text] [Related]
18. Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).
Shirakawa F; Yamashita U; Suzuki H
J Clin Immunol; 1985 Nov; 5(6):396-403. PubMed ID: 2935554
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
20. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
